SUBSCRIBE
SUBSCRIBE
News   Business

BioCurex Inc. Signs Consent to Transfer Abbott Laboratories’s RECAF Licensing Agreement to General Electric Company

July 2, 2007 | 
1 min read
RICHMOND, British Columbia, July 2, 2007 (PRIME NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that, upon request from Abbott Labs, the Company has signed a document transferring Abbott's RECAF licensing agreement to General Electric (GE).
Alliances
Abbott Laboratories
MORE ON THIS TOPIC
Closeup of businessman give money to robot. Man pass banknote bribe to robotic assistant. AI and technology. Vector illustration.
Funding
AI-Focused Fund Breakout Raises $114M To Support Early-Stage Biotechs
March 10, 2026
 · 
2 min read
 · 
Tristan Manalac
Cooperation concept. Vector of a businessman and a businesswoman connecting the bridge with a missing part
GLP-1s
Novo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute
March 9, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Dashed line from pills isolated on white
Cancer
Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies
March 9, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Vertex Terminates 20 in Reorganization Push
March 9, 2026
 · 
32 min read
 · 
BioSpace Editorial Staff